Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

E. Merck reports fibrinogen (gpIIb/IIIa) antagonists

June 21, 1996

Modified factor VII described for coagulation-related disorders

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

TFPI as tissue injury inhibitor

June 21, 1996

Pierre Fabre reveals cardiac cytoprotective agents

June 21, 1996

Roussel Uclaf discloses endothelin antagonists

June 21, 1996

Endothelin antagonist claimed by Roche

June 21, 1996

Thymosin beta4 as cystic fibrosis treatment

June 21, 1996

Ono reveals antioxidant TxA2 synthase/5-lipoxygenase inhibitors

June 21, 1996

Chymase/NO production inhibitors synthesized by Wakamoto

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...